BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 15736440)

  • 1. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
    Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
    Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer.
    Welfare M; Monesola Adeokun A; Bassendine MF; Daly AK
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):289-92. PubMed ID: 10207630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.
    Brockmöller J; Cascorbi I; Kerb R; Roots I
    Cancer Res; 1996 Sep; 56(17):3915-25. PubMed ID: 8752158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of N-acetyltransferase 2, glutathione S-transferase mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis.
    Kim WJ; Lee HL; Lee SC; Kim YT; Kim H
    J Urol; 2000 Jul; 164(1):209-13. PubMed ID: 10840461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2.
    Lee E; Huang Y; Zhao B; Seow-Choen F; Balakrishnan A; Chan SH
    J Toxicol Sci; 1998 Jul; 23 Suppl 2():140-2. PubMed ID: 9760451
    [No Abstract]   [Full Text] [Related]  

  • 8. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study.
    Wenzlaff AS; Cote ML; Bock CH; Land SJ; Schwartz AG
    Carcinogenesis; 2005 Feb; 26(2):395-401. PubMed ID: 15528218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population.
    Rouissi K; Ouerhani S; Marrakchi R; Ben Slama MR; Sfaxi M; Ayed M; Chebil M; El Gaaied AB
    Cancer Genet Cytogenet; 2009 Apr; 190(2):101-7. PubMed ID: 19380028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
    Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk (The Netherlands).
    van der Hel OL; Bueno-de-Mesquita HB; van Gils CH; Roest M; Slothouber B; Grobbee DE; Peeters PH
    Cancer Causes Control; 2005 Aug; 16(6):675-81. PubMed ID: 16049806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma.
    Moore LE; Huang WY; Chatterjee N; Gunter M; Chanock S; Yeager M; Welch B; Pinsky P; Weissfeld J; Hayes RB
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1823-7. PubMed ID: 16030123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population.
    Nakazato H; Suzuki K; Matsui H; Koike H; Okugi H; Ohtake N; Takei T; Nakata S; Hasumi M; Ito K; Kurokawa K; Yamanaka H
    Anticancer Res; 2003; 23(3C):2897-902. PubMed ID: 12926131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer.
    Chen J; Stampfer MJ; Hough HL; Garcia-Closas M; Willett WC; Hennekens CH; Kelsey KT; Hunter DJ
    Cancer Res; 1998 Aug; 58(15):3307-11. PubMed ID: 9699660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of GSTM1, GSTT1, GSTP1, NAT1, NAT2, EPHX1, MTR and MTHFR polymorphism on chromosomal aberration frequencies in human lymphocytes.
    Skjelbred CF; Svendsen M; Haugan V; Eek AK; Clausen KO; Kure EH; Tuimala JT; Svendsen MV; Norppa H; Hansteen IL
    Carcinogenesis; 2011 Mar; 32(3):399-405. PubMed ID: 21097530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: a comprehensive meta-analysis.
    Economopoulos KP; Sergentanis TN
    Eur J Cancer; 2010 Jun; 46(9):1617-31. PubMed ID: 20207535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer.
    Olshan AF; Weissler MC; Watson MA; Bell DA
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):185-91. PubMed ID: 10698480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study.
    Gertig DM; Stampfer M; Haiman C; Hennekens CH; Kelsey K; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1001-5. PubMed ID: 9829708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.